Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome
This study has been completed.
Study NCT00991068   Information provided by ZARS Pharma Inc.

First Received on October 6, 2009.   Last Updated on March 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carpal Tunnel Syndrome
More general conditions related to this trial
Cumulative Trauma Disorders
Median Neuropathy
Mononeuropathies
Nerve Compression Syndromes
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Sprains and Strains
Wounds and Injuries
Additional drug interventions recognized in this trial
Lidocaine
Tetracaine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
ZARS Pharma Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services